Rockwell Medical (RMTI)
Manufactures hemodialysis concentrates and develops adjacent renal-care products.
$8.07
At close+0.03 (+0.31%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 22 | 23 | 26 | 28 | 25 | 19 | 16 | 16 | 18 | 17 | 18 |
| Cost of revenue | 22 | 19 | 20 | 21 | 22 | 21 | 16 | 14 | 14 | 14 | 14 | 15 |
| Gross profit | 2 | 3 | 3 | 5 | 6 | 4 | 3 | 3 | 2 | 4 | 3 | 3 |
| 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |
| Selling & marketing | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| General & administrative | 3 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 3 | 4 | 4 | 4 |
| Operating income | −2 | −1 | −1 | 1 | 2 | −1 | −1 | −1 | −2 | 0 | −1 | −1 |
| 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −2 | −2 | −2 | 0 | 2 | −1 | −2 | −1 | −2 | −1 | −2 | −1 |
| Net income from continuing operations | −2 | −2 | −2 | 0 | 2 | −1 | −2 | −1 | −2 | −1 | −2 | −1 |
| Net income | −2 | −2 | −2 | 0 | 2 | −1 | −2 | −1 | −2 | −1 | −2 | −1 |
| EPS, basic | −$0.07 | −$0.53 | −$0.59 | $0.09 | $0.53 | −$0.23 | −$0.44 | −$0.43 | −$0.50 | −$0.14 | −$0.41 | −$0.34 |
| EPS, diluted | −$0.07 | −$0.53 | −$0.59 | $0.09 | $0.51 | −$0.23 | −$0.44 | −$0.43 | −$0.50 | −$0.14 | −$0.41 | −$0.34 |
| Weighted average shares, basic | 28 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Weighted average shares, diluted | 28 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| EBITDA | −1 | 0 | −1 | 1 | 3 | 0 | −1 | −1 | −1 | 0 | −1 | 0 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
| EBIT | −1 | 0 | −1 | 1 | 2 | 0 | −1 | −1 | −1 | 0 | −1 | −1 |